IPHA
Innate Pharma

1,485
Mkt Cap
$140.62M
Volume
38,792.00
52W High
$2.63
52W Low
$1.40
PE Ratio
-2.51
IPHA Fundamentals
Price
$1.50
Prev Close
$1.50
Open
$1.52
50D MA
$1.72
Beta
0.42
Avg. Volume
18,417.47
EPS (Annual)
-$0.6602
P/B
22.89
Rev/Employee
$75,431.50
$97.59
Loading...
Loading...
News
all
press releases
Innate Pharma's (IPHA) Buy Rating Reaffirmed at BTIG Research
BTIG Research reaffirmed a "buy" rating and issued a $8.00 price target on shares of Innate Pharma in a report on Thursday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Short Interest Update
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) was the target of a significant drop in short interest in the month of February. As of February 13th, there was short interest...
MarketBeat·14d ago
News Placeholder
Innate Pharma (NASDAQ:IPHA) Shares Up 3.6% - Here's What Happened
Innate Pharma (NASDAQ:IPHA) Trading 3.6% Higher - Time to Buy...
MarketBeat·17d ago
News Placeholder
Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
Regulatory News: Pursuant to the article L. 233-8 II of the French Code de Commerce and the article 223-16 of the French stock-market authorities (Autorit des Marchs Financiers, or AMF) General...
Business Wire·23d ago
News Placeholder
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced...
Business Wire·24d ago
News Placeholder
Innate Pharma (NASDAQ:IPHA) Stock Price Down 2.2% - Should You Sell?
Innate Pharma (NASDAQ:IPHA) Shares Down 2.2% - Should You Sell...
MarketBeat·1mo ago
News Placeholder
Innate Pharma (NASDAQ:IPHA) Shares Up 2.3% - Should You Buy?
Innate Pharma (NASDAQ:IPHA) Trading Up 2.3% - Time to Buy...
MarketBeat·3mo ago
News Placeholder
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
Regulatory News: Pursuant to the article L. 233-8 II of the French Code de Commerce and the article 223-16 of the French stock-market authorities (Autorit des Marchs Financiers, or AMF) General...
Business Wire·3mo ago
News Placeholder
Innate Pharma (OTCMKTS:IPHYF) Stock Price Up 13.1% - Time to Buy?
Innate Pharma (OTCMKTS:IPHYF) Trading 13.1% Higher - Time to Buy...
MarketBeat·3mo ago
News Placeholder
Innate Pharma Releases Its 2026 Financial Calendar
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) today released its 2026 financial calendar: March 26, 2026: Publication of 2025 financial statements May...
Business Wire·3mo ago
<
1
2
...
>

Latest IPHA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.